LRMR ▼ -16.5% - Larimar Therapeutics, Inc. $LRMR - Larimar Therapeutics Announces Three Poster Presentations for the Nomlabofusp Program at the Upcoming International Congress for Ataxia Research 05-NOV-2026 04:05 PM ET